Mary Tagliaferri

Mary A.
Tagliaferri was the founder of Bionovo, Inc. (founded in 2002) where she held the title of President, Secretary, Treasurer & Director from 2011 to 2012.
She currently holds the position of Independent Director at Enzo Biochem, Inc. (since 2020), Y-mAbs Therapeutics, Inc. (since 2024), and Nektar Therapeutics (since 2015), where she serves as Chief Medical Officer & Senior Vice President.
In her former roles, Dr. Tagliaferri served as a Director at Atossa Therapeutics, Inc. She was also an Independent Director at Rayzebio, Inc. from 2021 to 2024.
Additionally, she held the position of Secretary, Treasurer & Chief Regulatory Officer at Lighten Up Enterprises International, Inc. Furthermore, she served as Chief Medical Officer at Kanglaite USA, Inc. from 2012 to 2014.
Dr. Tagliaferri obtained her undergraduate degree from Cornell University in 1988.
She earned her doctorate degree from The University of California, San Francisco in 2002.
She also holds a graduate degree from the American College of Traditional Chinese Medicine, conferred in 1995.